FDA 483 - Esoterix Clinical Trials Services - June 27, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Esoterix Inc. (Colorado Coagulation) in Englewood, CO, a bioanalytical testing laboratory, revealed significant issues with data integrity and recordkeeping for a clinical trial study. Observations included a failure to update reported results after an identified error in the Laboratory Information System and a lack of maintained correspondence necessary to reconstruct study events. Additionally, the firm lacked a formalized procedure for maintaining internal and external communications related to clinical trial work.
ID · f42efb4d-b84d-45db-90c7-e11aa4128718